Brought to you by 
Shire buys Lotus Tissue Repair for $49.3mm plus earn-outs
27 Feb 2013
Executive Summary
Shire PLC is acquiring start-up biotech Lotus Tissue Repair Inc. (developing therapeutics for dermatology and wound healing) for $49.3mm in cash up front plus another $275mm in potential earn-outs based on safety and development milestones.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Shire buys Lotus Tissue Repair for $49.3mm plus earn-outs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice